Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
Clinical and Molecular Hepatology. 2018;24(4):351-357 
Sustained viral response in patients with hepatitis C and chronic kidney disease in hemodialysis and treatment with direct acting antivirals in the UMAE 71
Annals of Hepatology. 2020;19:11
P1-096: Eradication of chronic hepatitis C infection with direct acting antivirals is associated with reduction in fibrosis by Transient Elastography (FibroScan)
Journal of Viral Hepatitis. 2018;25:73-73
P1-107: Safety and efficacy of direct acting antivirals in genotype 4 chronic hepatitis C elderly patients, a pilot study
Journal of Viral Hepatitis. 2018;25:78-79
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
Hepatology International. 2022;16(5):1001-1019
P2-154: Efficacy of hepatitis B virus vaccination in genotype 4 chronic hepatitis C patients achieved sustained virologic response with direct acting antivirals
Journal of Viral Hepatitis. 2018;25:182-183
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
BMC Nephrology. 2020;21(1):
Chronic hepatitis C infection — Noninvasive assessment of liver fibrosis in the era of direct acting antivirals
Digestive and Liver Disease. 2019;51(2):183-189
Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
Scientifica. 2012;2012:1-22
Direct-Acting Antivirals in Chronic Hepatitis C Infection with Liver Cirrhosis
Hepatitis B and C. 2020;